Zum Hauptinhalt springen
Orthopaedics

“Life-changing” SMA therapies to be available on NHS in long-term

Hundreds more children with muscle-wasting condition spinal muscular atrophy (SMA) are to be offered potentially “life-changing” therapy on the NHS which could help them live years longer and attend primary school. From today, 2 innovative treatments for SMA – nusinersen and risd

EC
EuroClinics Editorial 13 May 2026
“Life-changing” SMA therapies to be available on NHS in long-term
Hundreds more children with muscle-wasting condition spinal muscular atrophy (SMA) are to be offered potentially “life-changing” therapy on the NHS which could help them live years longer and attend primary school. From today, 2 innovative treatments for SMA – nusinersen and risd

Read the full article at the source

EC

EuroClinics Editorial

Patient-facing healthcare guidance

Our editorial team distils the latest from European medical authorities (WHO Europe, ECDC, EMA, NHS, AEMPS, HAS) into plain-language guides for patients. Every article is reviewed against authoritative sources.

🏥

Need orthopaedics in Europe?

Browse verified clinics with transparent pricing and real reviews across 30+ countries.

Find a clinic →
Source. NHS England — NHS England, contains public sector information licensed OGL v3
Medical disclaimer. Articles are general information aggregated from third-party medical sources. They are NOT a substitute for in-person diagnosis or treatment. For personal medical guidance, consult a verified clinician or call your local emergency line (112 in the EU).